Daniela Rodriguez Rincon is a research leader in the Science and Emerging Technology group at RAND Europe. With expertise in biosecurity, engineering biology, and responsible research and innovation, her work focuses on the intersection of emerging technologies, public health and innovation policy, particularly in relation to pandemic preparedness. She has led and contributed to studies for organisations including the European Centre for Disease Prevention and Control, the Department for Science, Innovation and Technology, UKRI, CEPI and other public and research funders.
Rodriguez Rincon also has vast expertise in evaluation, having worked on the evaluation of the Industrial Strategy Challenges Fund (ISCF), the Strength in Places Fund (SIPF), the Global Challenges Research Fund (GCRF), the Newton Fund, the COVID-19 Genomics Consortium UK (COG-UK), two of the disease programmes of the European Centre for Disease Prevention and Control, and the MRC-DFID concordat agreement to support UK-led biomedical and public health research. Rodriguez Rincon has also contributed to the design of monitoring and evaluation frameworks, including the monitoring of the EU’s Cancer Mission, and the UK’s Metascience Unit and Australia’s NHMRC. Rodriguez Rincon is currently leading a framework contract for CEPI, in collaboration with Brown University’s Pandemic Centre, to support the development of CEPI’s monitoring, evaluation and learning (MEL) infrastructure.
Rodriguez Rincon has a Ph.D. in medicine (microbiology) from the University of Cambridge and an M.Sc. in medical microbiology from the London School of Hygiene and Tropical Medicine.
Ph.D. in medicine (microbiology), University of Cambridge; M.Sc. in medical microbiology, London School of Hygiene and Tropical Medicine; B.Sc. in biology, Complutense University of Madrid
Spanish; English; French (basic)
